Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by FRANK, A. L
Right arrow Articles by PORTER, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRANK, A. L
Right arrow Articles by PORTER, C. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 125, No. 4: 576-586
Copyright © 1987 by The Johns Hopkins University School of Hygiene and Public Health

research-article

INFLUENZA B VIRUS REINFECTION

ARTHUR L FRANK, LARRY H. TABER and CHERYL M. PORTER

From the Influenza Research Center, Department of Microbiology and Immunology and Department of Pediatrics, Baylor College of Medicine Houston, TX 77030

Send reprint requests to Dr. Arthur L Frank, Department of Pediatrics (M/C 856), University of Illinois College of Medicine, 840 South Wood Street, Chicago, IL 80612

Four outbreaks of Influenza B Infection occurred in Houston, Texas in the years 1976–1984. In the Houston Family Study, age-related infection and illness rates in the recent two epidemics resembled those reported previously. A total of 118 persons, including 35 children followed from birth, were followed longitudinally through this entire period and 331 persons were studied through at least two outbreaks. Fifty-nine (88%) of 67 children studied for four outbreaks were infected and 25% had a second infection; about half of the adults had one infection but only one of 51 was reinfected. Infection rates were proportionally lower for those followed through 2–3 outbreaks. Those with documented infection were protected decreasingly over time against reinfection and associated illness in subsequent epidemics. Such protection decreased in efficacy from 65% after 2–3 years, to 46% after 4–5 years, and to no protection after seven years.

influenza; orthomyxovirus infections; virus diseases


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
N. M. Ferguson, S. Mallett, H. Jackson, N. Roberts, and P. Ward
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals
J. Antimicrob. Chemother., April 1, 2003; 51(4): 977 - 990.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.